Brief: Kintor Pharmaceutical And Visum Announced Strategic Partnership To Expand Proxalutamide Manufacturing
14/04/2021 15:37
April 14 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* KINTOR PHARMACEUTICAL AND VISUM ANNOUNCED STRATEGIC
PARTNERSHIP
TO EXPAND PROXALUTAMIDE MANUFACTURING
Source text for Eikon: ID:nPn84yWSDa
Further company coverage: 9939.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint